Alcon AG | ALC - Sales Revenues

Stock Price
59.82
Daily Change
-1.52 -2.48%
Monthly
-7.46%
Yearly
-27.31%
Q1 Forecast
60.90

Alcon AG reported $2.59B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
AstraZeneca USD 15.19B 733M Sep/2025
Bayer EUR 9.66B 1.08B Sep/2025
Essilor EUR 6.87B 0 Sep/2025
Fresenius EUR 5.48B 100M Sep/2025
Fresenius Medical Care EUR 4.89B 100M Sep/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GRIFOLS EUR 1.87B 20M Sep/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.32B 890M Sep/2025
Novartis USD 13.91B 144M Sep/2025
Philips EUR 4.3B 38M Sep/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
Smith & Nephew USD 2.96B 134M Dec/2025
Sonova Holding CHF 1.82B 216.8M Dec/2025
UCB EUR 3.49B 129M Jun/2025